{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:50:54Z","timestamp":1787676654863,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2007007"],"award-info":[{"award-number":["APP2007007"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2009736"],"award-info":[{"award-number":["APP2009736"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jocn.2026.111940","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:07:01Z","timestamp":1771452421000},"page":"111940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nimodipine dosing and pharmacokinetic variability in subarachnoid hemorrhage patients"],"prefix":"10.1016","volume":"147","author":[{"given":"Judith","family":"Bellapart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Patricia","family":"Hern\u00e1ndez-Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa-Lassig","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Fourie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Livermore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.111940_b0005","doi-asserted-by":"crossref","unstructured":"Rinkel GJ, Feigin VL, Algra A, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane database of systematic reviews, 2002;(4):CD000277.","DOI":"10.1002\/14651858.CD000277"},{"issue":"4","key":"10.1016\/j.jocn.2026.111940_b0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMra052732","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"354","author":"Suarez","year":"2006","journal-title":"New England J Med, Review"},{"issue":"4","key":"10.1016\/j.jocn.2026.111940_b0015","first-page":"221","article-title":"Bad prognostic factors in patients with subarachnoidal bleeding due to ruptured aneurysm in intensive care","volume":"10","author":"Rodolfo-Castro","year":"2005","journal-title":"Archivos de Neurociencias"},{"issue":"5","key":"10.1016\/j.jocn.2026.111940_b0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/CON.0000000000000217","article-title":"Diagnosis and management of subarachnoid hemorrhage","volume":"21","author":"Suarez","year":"2015","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2026.111940_b0025","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jocn.2026.111940_b0030","first-page":"523","article-title":"The use of low dose heparin infusion to prevent delayed neurological deficits in aneurysmal subarachnoid hemorrhage","volume":"31","author":"Schreibman","year":"2019","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.jocn.2026.111940_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116539","article-title":"Impaired cerebrovascular reactivity may predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"407","author":"B\u00f8thun","year":"2019","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.jocn.2026.111940_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1570159X15666170915160707","article-title":"Spreading depolarization waves in neurological diseases: a short review about its pathophysiology and clinical relevance","volume":"17","author":"Ta\u015f","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jocn.2026.111940_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jocn.2024.03.016","article-title":"Nimodipine prophylaxis in aneurysmal subarachnoid hemorrhage, a question of tradition or evidence: a scoping review","volume":"123","author":"Bellapart","year":"2024","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2026.111940_b0050","doi-asserted-by":"crossref","unstructured":"Dorhout Mees SM, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000277, Jul 18.","DOI":"10.1002\/14651858.CD000277.pub3"},{"issue":"1","key":"10.1016\/j.jocn.2026.111940_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.wneu.2015.02.004","article-title":"Pharmacologic Management of Subarachnoid Hemorrhage","volume":"84","author":"Young","year":"2015","journal-title":"World Neurosurg"},{"issue":"11","key":"10.1016\/j.jocn.2026.111940_b0060","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1060028018778751","article-title":"Impact of early versus late intravenous followed by oral nimodipine treatment on the occurrence of delayed cerebral ischemia among patients with aneurysm subarachnoid hemorrhage","volume":"52","author":"Samseethong","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jocn.2026.111940_b0065","first-page":"1","article-title":"Nimodipine pharmacokinetics after intraventricular injection of sustained-release nimodipine for subarachnoid hemorrhage","author":"Macdonald","year":"2019","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.jocn.2026.111940_b0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12028-024-02182-0","article-title":"Nimodipine in aneurysmal subarachnoid hemorrhage: are old data enough to justify its current treatment regimen?","volume":"42","author":"Llompart-Pou","year":"2025","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.jocn.2026.111940_b0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40268-020-00322-3","article-title":"Nimodipine pharmacokinetic variability in various patient populations","volume":"20","author":"Mahmoud","year":"2020","journal-title":"Drugs R D"},{"issue":"1","key":"10.1016\/j.jocn.2026.111940_b0080","first-page":"7","article-title":"Cerebral arterial spasm: a controlled trial of nimodipine in subarachnoid hemorrhage patients","volume":"14","author":"Allen","year":"1983","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jocn.2026.111940_b0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3171\/jns.1988.69.5.0683","article-title":"Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery","volume":"69","author":"Ohman","year":"1988","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2026.111940_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3171\/jns.1991.74.1.0008","article-title":"Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery","volume":"74","author":"Ohman","year":"1991","journal-title":"J Neurosurg"},{"issue":"6674","key":"10.1016\/j.jocn.2026.111940_b0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"Pickard","year":"1989","journal-title":"Br Med J"},{"issue":"3\u20134","key":"10.1016\/j.jocn.2026.111940_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF01456369","article-title":"Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine","volume":"82","author":"Philippon","year":"1986","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.jocn.2026.111940_b0105","doi-asserted-by":"crossref","unstructured":"Neil-Dwyer G, Mee E, Dorrance D, Lowe D. Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J. 1987;8(Suppl K):41-7.","DOI":"10.1093\/eurheartj\/8.suppl_K.41"},{"issue":"5","key":"10.1016\/j.jocn.2026.111940_b0110","first-page":"381","article-title":"Clinical pharmacokinetics of nimodipine in normal and impaired renal function","volume":"4","author":"Kirch","year":"1984","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"10.1016\/j.jocn.2026.111940_b0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2165\/00002512-199202040-00002","article-title":"Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders","volume":"2","author":"Wadworth","year":"1992","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.jocn.2026.111940_b0120","first-page":"293","article-title":"The influence of age on the pharmacokinetics of nimodipine","volume":"34","author":"Muck","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jocn.2026.111940_b0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00228-009-0619-6","article-title":"Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort","volume":"65","author":"Zhao","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jocn.2026.111940_b0130","first-page":"229","article-title":"Nimodipine. Potential for drug-drug interactions in the elderly","volume":"6","author":"Muck","year":"1995","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.jocn.2026.111940_b0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jocn.2026.111940_b0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.18433\/jpps30960","article-title":"The impact of nimodipine administration through feeding tube on outcomes in patients with aneurysmal subarachnoid hemorrhage","volume":"23","author":"Isse","year":"2020","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.jocn.2026.111940_b0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00701-015-2447-z","article-title":"Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage","author":"Abboud","year":"2015","journal-title":"Acta Neurochir"},{"issue":"39","key":"10.1016\/j.jocn.2026.111940_b0150","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034789","article-title":"The efficacy of different nimodipine administration route for treating subarachnoid hemorrhage: a network meta-analysis","volume":"102","author":"Lei","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jocn.2026.111940_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12028-015-0230-x","article-title":"Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage","volume":"25","author":"Sandow","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jocn.2026.111940_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00268","article-title":"High compliance with scheduled nimodipine is associated with better outcome in aneurysmal subarachnoid hemorrhage patients cotreated with heparin infusion","volume":"8","author":"Wessell","year":"2017","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2026.111940_b0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12028-018-0575-z","volume":"30","author":"H\u00e4nggi","year":"2019","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.jocn.2026.111940_b0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","article-title":"Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk","year":"1988","journal-title":"J Neurosurg"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:24:56Z","timestamp":1777602296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S0967586826000913"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111940","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nimodipine dosing and pharmacokinetic variability in subarachnoid hemorrhage patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111940"}}